anastrozole has been researched along with Inappropriate GH Secretion Syndrome (Acromegaly) in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "This case highlights the dual benefit of tamoxifen therapy in the treatment of hormone-receptor-positive breast cancer and acromegaly." | 8.02 | Dual treatment of acromegaly and hormone-receptor-positive breast cancer with tamoxifen: a case report. ( Abramowitz, J; Chan, AVC; Ganji, N; Mirfakhraee, S, 2021) |
| "This case highlights the dual benefit of tamoxifen therapy in the treatment of hormone-receptor-positive breast cancer and acromegaly." | 4.02 | Dual treatment of acromegaly and hormone-receptor-positive breast cancer with tamoxifen: a case report. ( Abramowitz, J; Chan, AVC; Ganji, N; Mirfakhraee, S, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mirfakhraee, S | 1 |
| Chan, AVC | 1 |
| Ganji, N | 1 |
| Abramowitz, J | 1 |
1 other study available for anastrozole and Inappropriate GH Secretion Syndrome (Acromegaly)
| Article | Year |
|---|---|
Dual treatment of acromegaly and hormone-receptor-positive breast cancer with tamoxifen: a case report.
Topics: Acromegaly; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Ch | 2021 |